Introduction
Pediatric drug-resistant epilepsy poses significant therapeutic challenges, with approximately 30%-40% of children failing to achieve sustained seizure free status despite the combined use of antiseizure medications (ASMs).1–3…

Pediatric drug-resistant epilepsy poses significant therapeutic challenges, with approximately 30%-40% of children failing to achieve sustained seizure free status despite the combined use of antiseizure medications (ASMs).1–3…